Every material Form 8-K AMCON DISTRIBUTING CO has filed with the SEC since April 20, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
AMCON Distributing reported results for the fiscal year ended September 30, 2026, with diluted earnings per share of $2.52 compared with $0.62 in the prior year. Sales rose to $3.12 billion from $2.82 billion, and the retail health food segment posted an operating loss while the wholesale segment reported operating income.
Net income available to common shareholders was $2.4 million, compared with $0.6 million in fiscal 2025.
Sales were $3.12 billion, compared with $2.82 billion in fiscal 2025.
Wholesale distribution segment operating income was $25.5 million; retail health food segment operating loss was $0.6 million.
Shareholders' equity was $117.0 million at September 30, 2026.
AMCON Distributing Company received NYSE Texas authorization for a dual listing of its common stock and announced the listing takes effect August 13, 2026. The company keeps its primary listing on NYSE American and will trade under the same DIT ticker, so the filing describes a change in exchange venues rather than a change in the business.
NYSE Texas authorized the dual listing, with notification received on August 6, 2026.
Trading on NYSE Texas is expected to begin Thursday, August 13, 2026.
AMCON keeps its primary listing on NYSE American and uses the same DIT ticker symbol.
The filing does not report financial results, guidance, or any financial impact of the listing.
AMCON Distributing reported third-quarter fiscal 2026 results for the period ended June 30, 2026, with sales of $835.3 million, up from $739.6 million a year earlier. Net income available to common shareholders was $2.7 million, or $2.85 per diluted share, compared with $1.3 million, or $1.42 per diluted share, in the prior-year quarter. The filing contains no guidance for future periods.
Q3 sales were $835.3 million, versus $739.6 million in the same quarter last year.
Diluted EPS was $2.85, versus $1.42 a year earlier; net income was $2.7 million, versus $1.3 million.
Operating income was $6.2 million, versus $4.9 million, including a $1.8 million gain on sales of real estate.
Nine-month diluted EPS was $1.40, versus $0.08 in the prior year; the company paid $0.12 per share in quarterly dividends.
AMCON Distributing reported a net loss available to common shareholders of $2.2 million, or $2.34 per share, for the fiscal second quarter ended March 31, 2026, compared with a loss of $1.6 million, or $1.72 per share, a year earlier. Sales rose to $715.7 million from $619.5 million, but the company posted an operating loss for the quarter, which matters to shareholders because profit weakened even as revenue grew.
Quarterly net loss of $2.2 million ($2.34 per share) versus a $1.6 million loss ($1.72 per share) in the prior-year quarter
Quarterly sales of $715.7 million, up from $619.5 million; operating loss of $0.4 million versus operating income of $0.5 million a year earlier
Six-month net loss of $1.4 million ($1.49 per share) versus $1.2 million ($1.35 per share); shareholders' equity was $112.4 million at March 31, 2026
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every AMCON DISTRIBUTING CO filing is on SEC EDGAR ↗. 8-K briefs of other companies →